← Insider buys
CUE

Cue Biopharma, Inc. · Healthcare

Director Christopher A Marlett sold $394K of Cue Biopharma, Inc.

Sold$394,114
$15.94Price
24,732Shares
−3%Stake

What CUE did after the filing

Prices for CUE after this filing aren't in yet.

Traded Tue, Dec 17. Filed Thu, Dec 19, 5:35 PM ET, after the close. Not investment advice.